African Malaria Partnership | Health for all | Explore GSK | GlaxoSmithKline

African Malaria Partnership

The African Malaria Partnership (AMP) was established in 2001 to improve the prevention and treatment of malaria in sub-Saharan Africa.  Since then we have committed over £3 million on initiatives to combat the disease. Find out more about how the Partnership is working to change behaviour in communities at risk from malaria.